Abstract
Introduction

Various extrahepatic manifestations of chronic hepatitis B infection have been reported (1-3). Polyarteritis nodosa (PAN) is the most typical extrahepatic manifestation. However, current estimates of hepatitis B-related PAN are now less than 10% among all PAN patients (4, 5). We encountered a case of hepatitis B-related PAN, diagnosed during the course of alithiasic cholecystitis. Necrotizing vasculitis was observed in the biopsy specimen of the gallbladder and liver, and mononeulitis multiplex was also complicated in the patient. The therapy of plasmapheresis and glucocorticoid with lamivudine exerted a significant effect without exacerbation of liver dysfunction.
Case Report
A 64-year-old man, who had been previously treated for type 2 (Fig. 1) . Although the liver parenchyma 
t e c t e d wi t h i n t h e v a sc u l i t i s l e s i o n ( F i g 2 C) . No p o s i t i v e s t a i n i n g wa s f o u n d i n t h e n e g a t i v e c o n t r o l s e c t i o n s ( F i g 2 E -G) . T h e p o s i t i v e c o n t r o l wa s t h e HB e a n t i g e n -p o s i t i v e p a t i e n t wi t h c h r o n i c h e p a t i t i s B ( F i g 2 D&H) . NRS : n o r ma l r a b b i t s e r u m ( × 1 0 0 )
F i g u r e 3 . I g G a n d c o mp l e me n t d e p o s i t i o n wa s d e t e c t e d i n t h e n e c r o t i z i n g v a s c u l i t i s l e s i o n . T h e s p e c i me n s o b t a i n e d f r o m t h e g a l l b l a d d e r a n d l i v e r o f t h e p a t i e n t we r e i mmun o s t a i n e d wi t h a n t i b o d i e s a g a i n s t I g G a n d c o mp l e me n t 3 ( C3 ) . P o s i t i v e s t a i n i n g o f I g G a n d C3 wa s o b s e r v e d i n t h e i nf l a me d v a s c u l i t i s l e s i o n o f t h e g a l l b l a d d e r ( F i g 3 A&C) . I n t h e l i v e r , s t r o n g I g G ( F i g 3 B ) a n d s l i g h t C3 d e p o s i t i o n ( F i g 3 D) we r e o b s e r v e d i n t h e l e s i o n o f t h e n e c r o t i z i n g v a s c u l i t i s , r e s p e c t i v e l y . No p o s i t i v e s t a i n i n g wa s o b s e r v e d i n t h e n e g at i v e c o n t r o l s e c t i o n s ( F i g 3 E &F ) . ( × 1 0 0 )
Since the diagnosis of hepatitis B-related PAN was made, we first administrated lamivudine on June 18. However, progression of peripheral neuropathy necessitated the addition of plasmapheresis (total 8 times during 3 weeks) glucocorticoid therapy including methylprednisolone pulse therapy
(250 mg/day), followed by 30 mg of oral prednisolone, in accordance with insulin therapy for type 2 diabetes (Fig. 4) . He was discharged on September 17 with a final prescription of 20 mg/day of oral prednisolone and lamivudine. As indicated in Fig. 4 , these treatments brought improvement of neurological signs and inflammatory reactions without exacerbation of liver function. Hepatitis B viremia was also improved during the treatment (Table 1) .
Discussion
Immunohistochemically, HBc antigen was not observed in the inflamed vasculitis lesions. Previous reports suggest that circulating immune complex, consisting of hepatitis B antigens and antibodies plays an important role in the pathogenesis of vasculitic lesions of hepatitis B-related PAN (5).
However, Dienstag (6) 
mechanism. It is possible to speculate that antibodydependent cell-mediated cytotoxicity ( ADCC ) or complement-dependent cytotoxicity (CDC), triggered by HBV infection, might be involved in the pathologic process of the vascular damage in such a case.
Plasmapheresis is considered to be the pivotal therapy to improve hepatitis B-related PAN (7, 8 
